home / stock / bnr / bnr news

BNR News and Press, Burning Rock Biotech Limited From 09/08/23

Stock Information
Company Name: Burning Rock Biotech Limited
Stock Symbol: BNR
Market: NASDAQ
Website: brbiotech.com
Menu
BNR BNR Quote BNR Short BNR News BNR Articles BNR Message Board
Get BNR Alerts

News, Short Squeeze, Breakout and More Instantly...
BNR - Theratechnologies, Aziyo Biologics, Neptune Wellness among healthcare movers

2023-09-08 10:00:08 ET More on Health Care Select Sector SPDR Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Dividend scorecard for Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) ...
BNR - WHLR, NBSE and LGHL among pre-market losers

2023-09-08 08:45:35 ET Losers: Grom Social Enterprises ( GROM ) -35% . Digital Media Solutions ( DMS ) -26%. Karat Packaging ( KRT ) -17% on pricing secondary stock offering at $21 a share . NeuBase Therapeutics ( NBSE ) -14% . Rosec...

BNR - Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell

GUANGZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is delighted to announce that our personalized Minimal Residual Disease (MRD) product, CanCatch ® (PROPHET TM pane...

BNR - Burning Rock Biotech Limited (BNR) Q2 2023 Earnings Call Transcript

2023-08-31 15:12:10 ET Burning Rock Biotech Limited (BNR) Q2 2023 Earnings Conference Call August 31, 2023, 08:00 AM ET Company Participants Yusheng Han - Founder, Chairman and CEO Leo Li - CFO Conference Call Participants Presentation Operator ...
BNR - Expected earnings - Burning Rock Biotech Limited

Burning Rock Biotech Limited (BNR) is expected to report for Q2 2023

BNR - Burning Rock Biotech GAAP EPS of -$0.18, revenue of $20.2M

2023-08-31 02:15:02 ET Burning Rock Biotech press release ( NASDAQ: BNR ): Q2 GAAP EPS of -$0.18. Revenue of $20.2M (+11.8% Y/Y). Cash, cash equivalents, restricted cash and short-term investments were $101.1 million as of June 30, 2023. For further details see: ...

BNR - Burning Rock Reports Second Quarter 2023 Financial Results

GUANGZHOU, China, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today r...
BNR - Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023

GUANGZHOU, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today a...

BNR - Burning Rock Announces Resignation and Appointment of Directors

GUANGZHOU, China, June 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today a...

BNR - Burning Rock Narrows Losses With Drug Research As New Driver

2023-06-08 09:56:00 ET Summary Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses. Revenues from R&D services for drug companies more than doubled, becoming the co...
Previous 10 Next 10